期刊文献+

移植物抗肿瘤效应及其在实体瘤治疗中的意义

Graft-versus-tumor effect and its significance in the treatment of solid tumor
下载PDF
导出
摘要 异基因造血干细胞移植 (Allo HSCT)因具有独特的移植物抗恶性病效应常用来治疗某些恶性血液病 ,近年来Allo HSCT在临床上尝试性地用来治疗某些实体瘤并取得了一定的疗效 ,现就Allo Allogeneic hematopoietic stem cell transplantation(Allo-HSCT) has proved to have a unique immune-mediated antitumor effect in patients with hematologic malignancies. However,recently more investigators have come to recognize that antineoplastic effect mediated by immunopotent donor T-cells transplanted with the stem cell allograft can be induced against solid malignancies and achieved some therapeutic effect.This article reviews the graft-versus-tumor effect and its immunotherapeutic mechanism to investigate the potential of allogeneic immunotherapy for treating solid tumor.
作者 翟光林 姜藻
出处 《东南大学学报(医学版)》 CAS 2004年第4期282-285,共4页 Journal of Southeast University(Medical Science Edition)
关键词 移植物 抗肿瘤效应 实体瘤 治疗 免疫机制 异基因造血干细胞移植 hematopoietic stem cell transplantation transplants neoplasms/therapy lymphocyte transfusion review literature
  • 相关文献

参考文献25

  • 1NIEDA M,NICOL A,KIKUCHI A,et al. Dendritic cells stimulate the expansion of bcr-abl specific CD8+ T cell with cytotoxic activity against leukemia cells from patients with chronic myeloid leukemia[J]. Blood,1998,91(3):977-983.
  • 2KUMMAR S,LSBII A,YANG H K,et al. Modulation of graft-versus-tumor effects in a murine allogeneic bone marrows transplantation model by tumor-derived transforming growth factor-β1[J]. Biol Blood Marrow Transplant,2001,7(1):25-30.
  • 3EIBL B,SCHWAIGHOFER H,NACHBAUR D,et al. Evident for a graft-versus-tumour effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer[J]. Blood,1996,88(4):1501-1508.
  • 4CHILDS R,CLAVE E,TISDALE J,et al. Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant:evidence for a graft-versus-tumor effect[J]. J Clin Oncol,1999,17(7):2044-2049.
  • 5BREGNI M,DODERO A,PECCATORI J,et al. Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer[J]. Blood,2002,99(11):4234-4236.
  • 6HERRAD B,STEFAN N,THOMAS B,et al. Kinetics of the graft-versus-leukemia response after donor lymphocyte infusion for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation[J]. Blood,1998,92:3582-3590.
  • 7RINI B I,ZIMMERMAN T,STADLER W M,et al. Allogeneic stem-cell transplantation of enal cell cancer after nonmyeloablative chemotherapy:feasibility,engraftment,and clinical results[J]. J Clin Oncol,2002,20(8):2017-2024.
  • 8HATTORI K,HIRANO T,OSHIMI K,et al. A metalloproteinase inhibitor prevents acute graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic bone marrow transplantation[J]. Leukemia Lymphoma,2000,38(5-6):553-561.
  • 9GOULMY E,SCHIPPER R,POOL J,et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation[J]. N Engl J Med,1996,334(5):281-285.
  • 10AVERSA F,TERENZI A,CAROTTI A,et al. Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia[J].J Clin Oncol,1999,17(5):1545-1550.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部